Week 6 - Receptors in cell signalling, principles of receptor-mediated endocytosis Flashcards

1
Q

How can chemical signals be classified?

A

According to their function
- Hormones (signalling between cells in different tissues via the circulation)
- Neurotransmitters (signalling at specialised cell junctions in the nervous system, synapses)
- Local chemical mediators (signalling between adjacent cells in the same tissue)
A single molecule may fall into more than 1 of these categories depending on where it is synthesised and released, and it’s site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a ligand?

A

Any small molecule that binds specifically to a receptor site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an antagonist?

A

A ligand that does not cause activation upon binding

- It opposes the action of the ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are partial agonists?

A

Agonists which stimulate a receptor but are unable to elicit the maximum cell response possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a receptor?

A

A molecule that recognises specifically a second molecule (ligand) or family of molecules, and which in response to ligand binding brings about regulation of a cellular process
- In the unbound state, it is functionally silent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some examples of the roles of receptors in cellular physiology?

A
  • Signalling by hormones/local chemical mediators
  • Neurotransmission
  • Cellular delivery
  • Control of gene expression
  • Cell adhesion
  • Modulation of the immune response
  • Sorting of intracellular proteins
  • Release of intracellular calcium stores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between the binding affinity of enzymes and that of ligands?

A

Affinity of ligand binding at receptor sites is generally much higher than binding of substrates and allosteric regulators to enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can receptors be classified?

A

According to the specific physiological signalling molecule (agonist) that they recognise
- Sub-classification: affinity of a series of antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is an acceptor?

A

A receptor whose basic function can be carried out without the interaction of a ligand
- Ligand binding alone produces no response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do cells respond to a chemical messenger?

A

It must produce specific receptor proteins

  • These recognise and produce a response to the signalling molecule
  • Interaction of the signalling molecule with its specific receptor must then result in the activation of a cellular process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is signal transduction?

A

Most signalling molecules are unable to cross the plasma membrane, so there are some common mechanisms to transduce an extracellular hydrophilic signal into and intracellular event:

  • Membrane-bound receptors with integral ion channels
  • Membrane-bound receptors with integral enzyme activity
  • Membrane-bound receptors which couple to effectors through transducing proteins
  • Intracellular receptors for hydrophobic ligands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some similarities between receptor binding sites and the active sites of enzymes?

A
  • Binding at both receptor sites and enzyme sites is specific
  • The specificity of binding is governed by the shape of the binding cleft in the receptor/enzyme site
  • The specificity of binding confers specificity to the regulation of processes in which receptors are involved or the specificity for substrate of an enzyme
  • Binding is most often reversible
  • Binding induces a conformational change and a change in the activity of the molecule
  • No chemical modification of the ligand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a difference between receptor binding sites and the active sites of enzymes?

A

The affinity of ligand binding at receptor sites is generally much higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 4 major classes of receptors involved in cellular signalling?

A
  • Membrane-bound receptors with integral ion channels
  • Membrane-bound receptors with integral enzyme activity
  • Membrane-bound receptors with no integral enzyme or channel activity
  • Intracellular receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do membrane-bound receptors with integral ion channels work?

A

Agonist binding to ligand-gated ion channels results in a change in conformation and opening of a gated channel

  • This permits the flow of ions down an electrochemical gradient
  • This transduces the signal into an electrical event at the plasma membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the subunit structure of the ‘classical’ ligand-gated ion channel family?

A

They have similar pentameric subunit structures

- Subunits have 4 transmembrane domains, 1 of which forms the lining to the channel pore

17
Q

What are some examples of ligand-gated ion channels?

A
  • Nicotinic acetylcholine receptors
  • Gamma amino-butyric acid receptors
  • Glycine receptors
18
Q

How do membrane-bound receptors with integral enzyme activity work?

A

Agonist binding to the extracellular domain of these receptors causes a conformational change
- This activates an intrinsic enzyme activity contained within the protein structure of the receptor

19
Q

Give an example of a membrane-bound receptor with integral enzyme activity and describe how it works

A

Tyrosine kinase-linked receptors

  • Binding of hormone to extracellular binding sites activates protein kinase activity in the cytoplasmic domain of the receptor protein
  • This autophosphorylates tyrosine residues on the cytoplasmic domain of the receptor
  • These are recognised by transducing proteins or directly by enzymes containing phosphotyrosine recognition sites
  • On association with receptor or transducing protein, effector enzymes become activated allosterically
  • This transduces the message into an intracellular chemical event
20
Q

How do membrane-bound receptors with no integral enzyme or channel activity work?

A
  • 7 transmembrane domain receptors couple to effectors molecules via a transducing molecule (a G-protein)
  • This family of receptors are also know as the G-protein coupled receptor family)
  • Effectors may be enzymes or ion channels
  • A wide variety of extracellular signalling molecules utilise specific 7 transmembrane domain receptors
  • Receptor binding results in a conformational change which activates GDP/GTP exchange in GTP-binding regulatory proteins
  • This transduces the message onto an enzyme or channel in the membrane
21
Q

Give some examples of membrane-bound receptors with no integral enzyme or channel activity

A
  • Muscarine ACh receptor
  • Adrenoceptors
  • Dopamine receptors
22
Q

How do intracellular receptors work?

A
  • Hydrophobic ligands penetrate the plasma membrane
  • They bind to monomeric receptors and are stabilised by association with heat shock or chaperone proteins
  • The activated receptor dissociates from the chaperone protein and translocates to the nucleus
  • It then binds to control regions in DNA defined by specific sequences, thereby regulating gene expression
  • The effects of intracellular activation are slow in onset as transcription and translation are required
23
Q

How does phagocytosis occur?

A

In response to the binding of a particle to receptors in plasma membrane

  • The cell extends pseudopods
  • These permit further receptor interactions and membrane evagination and particle internalisations
  • Internalised phagosomes fuse with lysosomes to form phagolysosomes in which the particulate material is degraded
24
Q

What is pinocytosis?

A

Invagination of the plasma membrane to form a vesicle

- Permits uptake of extracellular salutes and retrieval of plasma membrane

25
Q

What are the 2 forms of pinocytosis?

A
  • Fluid-phase

- Receptor-mediated endocytosis

26
Q

What is receptor-mediated endocytosis?

A

Specific binding of molecules to cell surface receptors

27
Q

What is an example of receptor-mediated endocytosis and explain how it occurs?

A

Uptake of cholesterol

  • Low density lipoproteins originate in the liver
  • Animal cells that require cholesterol synthesise cell surface receptors that specifically recognise apoprotein B (found on LDL)
  • LDL receptors are localised in clusters over coated pits
  • Coated pits invaginate and pinch off from the plasma membrane to form coated vesicles
  • Coated vesicles are quickly uncoated (driven by ATP)
  • The uncoated vesicles then fuse with larger smooth muscle vesicles called endosomes
  • The pH of the endosomes is maintained between approximately 5.5-6.0 by an ATP-dependent proton pump
  • At this pH, the LDL receptor has low affinity for the LDL particle and the 2 dissociate
  • The transmembranous receptors are sequestered to a domain within the endosome membrane which buds off as a vesicle (this recycles the LDL-receptor to the plasma membrane)
  • The endosomes containing the LDL fuse with lysosomes such that the cholesterol can be hydrolysed from the esters and released into the cell
  • Hence the receptor is recycled and the ligand is degraded
28
Q

How is the clathrin coat attached to the plasma membrane?

A

By a number of integral membrane adaptor proteins

- These form associations with both the clathrin and receptors

29
Q

What is another name for endosomes?

A

CURL

- Compartment for the uncoupling of receptor and ligand

30
Q

How does coated pit formation occur?

A

Spontaneously and non-specifically

31
Q

What mutations are there that can affect the LDL receptor?

A
  • Receptor deficiency: mutations that prevent expression of LDL receptor
  • Non-functional receptor: no binding of LDL, normal coated pits and internalisation
  • Normal receptor binding but no internalisation: due to deletion in the C-terminal of the receptor that makes interaction with the coated pits. LDL receptors are found distributed over the whole call surface in these patients
32
Q

How are ferric (Fe3+) ions taken up?

A
  • 2 Fe3+ ions bind to apotransferrin forming transferrin in the circulation
  • Transferrin binds to the transferrin receptor at neutral pH and is internalised in the same way as LDL
  • On reaching the acidic endosome, the Fe3+ ions are released from the transferrin
  • Apotransferrin remains associated with the transferrin receptor
  • The complex is sorted in the CURL for recycling back to the plasma membrane, where at pH 7.4, the apotransferrin dissociates from the transferrin receptor again
  • The ligand and receptor are hence recycled
33
Q

How does the uptake of occupied insulin receptors occur?

A
  • The insulin receptor only congregates over coated pits when the agonist is bound
  • Insulin binding probably induces a conformational change in the insulin receptor, allowing it to be recognised by the coated pit
  • In the endosome insulin remains bound to the receptor
  • The complex is targeted to the lysosomes for degradation
  • This mechanism allows down-regulation of insulin receptors on the membrane surface, desensitising the cell to a continued presence of high-circulating insulin concentrations
  • The ligand has been degraded, as has the receptor
34
Q

What is transcytosis?

A

When ligands that remain bound to their receptors are transported across the cell

35
Q

How can membrane-enveloped viruses and toxins enter cells using endocytic pathways?

A

They exploit endocytic pathways to enter cells after adventitious binding to receptors in the plasma membrane

  • Once in the endosome, where the acid pH is favourable, the viral membrane is able to fuse with the endosomal membrane
  • This releases viral RNA into the cell
  • It can then be translated and replicated to form new viral particles